Both in Pharmaceuticals
Mannkind vs Nektar Therapeutics
Over the past year MNKD returned −31.9% and NKTR returned −37.0%; their daily moves had a correlation of 0.09.
MNKD −31.9% NKTR −37.0%Growth of $1, one year, split-adjusted
| Metric | MNKD | NKTR |
|---|---|---|
| Price | $3.73 | $37.76 |
| Market cap | $1.20B | $1.29B |
| Today | +2.19% | +2.19% |
| 1 month | −2.4% | −10.6% |
| 6 months | +30.4% | −55.1% |
| Year to date | −34.2% | −10.7% |
| 1 year | −33.3% | −41.8% |
| Revenue growth (YoY) | +42.9% | −9.3% |
| Gross margin | 73.0% | 100.0% |
| Net margin | −17.4% | −401.0% |
| P/E (TTM) | — | — |
| Price / sales | 3.0× | 23.6× |
| Net cash | -$373.9M | $684.3M |
| Dividend yield | — | — |
| Volatility (60d) | 56.4% | 69.9% |
| Short % of float | 8.2% | 21.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).